Whether combined with skin rejuvenation, hormone therapy, or recovery programs, our experts create a personalized plan to enhance results and support your overall well-being
Because human safety data are still limited and BPC-157 is not FDA-approved, patient selection matters
In Phase 2 trials, retatrutide produced approximately 24% mean weight loss at 48 weeks at 12 mg, compared with about 22.5% for tirzepatide at 15 mg in the SURMOUNT-1 trial though direct head-to-head data is not yet available
Furthermore, lifestyle and environmental factors such as sexual violence, sexually transmitted diseases, stress and nutritional insufficiency among many others have also been associated with reduced fertility (43)
This can happen due to reduced appetite or food intake, as it becomes more challenging to consume enough protein, which is necessary for maintaining lean muscle mass